VHLD

(redirected from von Hippel-Lindau disease)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
AcronymDefinition
VHLDVon Hippel-Lindau Disease
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Pediatric endocrine screening for von Hippel-Lindau disease: Benefits and the challenge of compliance.
Troeger, "Bilateral papillary cystadenoma of the mesosalpinx: A rare manifestation of Von Hippel-Lindau disease," Archives of Gynecology and Obstetrics, vol.
Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene.
Genetic analysis of von Hippel-Lindau disease. Hum Mutat 2010; 31:521-37.
Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: Findings, results, and indications.
Germline mutations in the Von Hippel-Lindau disease ( VHL ) gene in families from North America, Europe, and Japan.
An estimated 20 to 50% of hypernephromas are associated with Von Hippel-Lindau disease. These tumors account for 2 to 3 % of all neoplasms and spread mostlyby direct extension into the renal pelvis and the bloodstream; thus, early spread to the lungs is expected.
Blumbergs, "Metastasis of renal cell carcinoma to haemangioblastoma of the spinal cord in von Hippel-Lindau disease: case report and review of the literature," Pathology, vol.
Plasma normetanephrine and metanephrine for detecting pheochromocytoma In von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
Stratakis compiles 11 articles on the genetics of endocrine tumors, from classic multiple neoplasia syndromes to various germline or somatic mutations in sporadic tumors: multiple endocrine neoplasia type 1, 2, and 4; von Hippel-Lindau disease; Carney complex; pheochromocytomas and paragangliomas; Carney triad; pituitary, thyroid, and parathyroid tumors; and endocrine tumors associated with neurofibromatosis type 1, Peutz-Jeghers syndrome, and other familial neoplasia syndromes.
Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.